Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
Center for Cell Death, Injury & Regeneration, Departments of Drug Discovery & Biomedical Sciences and Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Toxicol Appl Pharmacol. 2022 Jun 15;445:116043. doi: 10.1016/j.taap.2022.116043. Epub 2022 May 2.
Acetaminophen (APAP) hepatotoxicity, a leading cause of acute liver failure in western countries, is characterized by mitochondrial superoxide and peroxynitrite formation. However, the role of iron, especially as facilitator of lipid peroxidation (LPO), has been controversial. Our aim was to determine the mechanism by which iron promotes cell death in this context. Fasted male C57BL/6J mice were treated with the iron chelator deferoxamine, minocycline (inhibitor of the mitochondrial calcium uniporter) or vehicle 1 h before 300 mg/kg APAP. Deferoxamine and minocycline significantly attenuated APAP-induced elevations in serum alanine amino transferase levels and hepatic necrosis at 6 h. This protection correlated with reduced 3-nitro-tyrosine protein adducts; LPO (malondialdehyde, 4-hydroxynonenal) was not detected. Activation of c-jun N-terminal kinase (JNK) was not affected but mitochondrial release of intermembrane proteins was reduced suggesting that the effect of iron was at the level of mitochondria. Co-treatment of APAP with FeSO exacerbated liver injury and protein nitration and triggered significant LPO; all effects were reversed by deferoxamine. Thus, after APAP overdose, iron imported into mitochondria facilitates protein nitration by peroxynitrite triggering mitochondrial dysfunction and cell death. Under these conditions, endogenous defense mechanisms largely prevent LPO. However, after iron overload, protein nitration and LPO contribute to APAP hepatotoxicity.
对乙酰氨基酚(APAP)肝毒性是西方国家急性肝衰竭的主要原因,其特征是线粒体超氧阴离子和过氧亚硝酸盐的形成。然而,铁的作用,尤其是作为脂质过氧化(LPO)促进剂的作用一直存在争议。我们的目的是确定铁在这种情况下促进细胞死亡的机制。禁食雄性 C57BL/6J 小鼠在给予 300mg/kg APAP 前 1 小时用铁螯合剂去铁胺、米诺环素(线粒体钙单向转运体抑制剂)或载体处理。去铁胺和米诺环素显著减弱了 APAP 诱导的血清丙氨酸氨基转移酶水平升高和 6 小时时的肝坏死。这种保护作用与减少 3-硝基酪氨酸蛋白加合物相关;未检测到脂质过氧化(丙二醛、4-羟基壬烯醛)。c-jun N 末端激酶(JNK)的激活没有受到影响,但跨膜蛋白的线粒体释放减少,表明铁的作用在线粒体水平。APAP 与 FeSO 共同处理加剧了肝损伤和蛋白硝化,并引发了明显的 LPO;所有影响均被去铁胺逆转。因此,APAP 过量后,进入线粒体的铁通过过氧亚硝酸盐促进蛋白硝化,引发线粒体功能障碍和细胞死亡。在这些条件下,内源性防御机制在很大程度上阻止了 LPO。然而,在铁过载后,蛋白硝化和 LPO 会导致 APAP 肝毒性。